This report was pretty darn technical and way above my head, but from what I understood:
-
-
- Lewy bodies are formed by the aggregation of alpha-synuclein proteins long before loss of dopaminergic neurons becomes apparent
- Alpha-synuclein proteins appear to affect the immune system to produce an inflammatory response in the body (and brain)
- The inflammatory factor interleukin-1-Beta was found at significantly higher levels in Parkinson’s patients’ blood samples
-
This particular study can be found on PubMedCentral. Unfortunately, I seem to have lost the link (or WordPress lost it for me). I Blame The Parkinson’s©
Howsomever, as Pogo the Possum (or Albert the Alligator) might have said, here is an article on biomarkers, published even more recently:
Blood biomarkers in Parkinson’s cluster analysis and prognosis
“Baseline clinical subtyping identified a pro‐inflammatory biomarker profile significantly associated with a severe motor/nonmotor disease phenotype, lending biological validity to subtyping approaches. No blood biomarker predicted motor or nonmotor prognosis. (Mov Disord. 2020 Feb; 35(2): 279–287. Published online 2019 Nov 6. doi: 10.1002/mds.27888)
In other words, inflammation seems to be associated with PD, but the blood biomarkers they used didn’t correlate to progression of the disease.
In the meanwhile, we’re still searching…
###